Mr. Bill Jackson reports

VECTOR SCIENCE & THERAPEUTICS ANNOUNCES TOMMY THOMPSON AS CHAIRMAN OF THE BOARD

Tommy Thompson, former governor of Wisconsin and U.S. Secretary of Health and Human Services, has joined Vector Science and Therapeutics Corp. as chairman of the board.

Mr. Thompson's appointment brings exceptional health care policy expertise and leadership experience to Vector as the company advances its mission to equip physicians, surgeons and clinicians with site-directed interventions where precision matters and systemic risk is unacceptable. The company's developmental work is focused in pain management, regenerative medicine, orthopedics and cancer. Mr. Thompson's distinguished career includes serving as Wisconsin's longest-serving governor (1987 to 2001) and leading the U.S. Department of Health and Human Services under President George W. Bush (2001 to 2005), where he oversaw Medicare modernization and major health care initiatives.

During his tenure as HHS secretary, Mr. Thompson championed health care innovation, oversaw the implementation of the Medicare prescription drug benefit and led efforts to modernize the nation's health care infrastructure. As Wisconsin governor, he was known for pioneering welfare reform and promoting economic development, particularly in the health care and biotechnology sectors.

"Vector Science and Therapeutics represents exactly the kind of innovative thinking we need to address the challenges facing modern health care," said Mr. Thompson. "Vector's transdermal drug delivery platforms will deliver significant advances in targeted therapy delivery, offering the potential to improve treatment efficacy while minimizing systemic side effects. Delivering biomechanical and therapeutic interventions into targeted anatomy is becoming increasingly important as our population ages and becomes increasingly dependent on polypharmacy for a range of conditions. I am excited to work with the entire Vector team to help advance these breakthrough technologies."

Throughout his career, Mr. Thompson has been a strong advocate for health care innovation and has served on numerous health-care-related boards and advisory committees. His experience navigating complex regulatory environments and understanding of both public-sector and private-sector health care dynamics will be invaluable as Vector continues to develop and commercialize its therapeutic platforms.

"We are honoured to welcome Tommy Thompson as chairman of our board," said Bill Jackson, chief executive officer of Vector Science and Therapeutics. "His unparalleled experience in health care policy, combined with his deep understanding of Wisconsin's innovation ecosystem, makes him the ideal leader to guide Vector's strategic direction as we work to bring breakthrough biomechanical and transdermally delivered therapies to clinicians and patients."

About Vector Science and Therapeutics Corp.

Founded in 2024 and located in Mequon, Wis., Vector Science and Therapeutics develops active transdermal and localized drug delivery platforms to equip clinicians with site-directed interventions where precision matters and systemic risk is unacceptable. Vector Science and Therapeutics is publicly traded on the TSX Venture Exchange under the ticker symbol PAIN.